Item 7.01 Regulation FD Disclosure OnJanuary 11, 2022 ,Avanos Medical, Inc. (the "Company") posted an investor presentation to its website at https://avanos.investorroom.com/. A copy of the investor presentation is attached as Exhibit 99.1 to this Current Report on Form 8-K. The presentation will be used by the Company in its prepared remarks at theJ.P. Morgan Healthcare Conference . The presentation indicates that the Company's 2021 adjusted earnings per share ("EPS") will likely fall below the$1.10 to$1.20 per share guidance previously provided, as improved gross margins will finish short of expectations during the three months endedDecember 31, 2021 . However, that statement does not take into account certain expected tax benefits. Inclusive of the additional expected tax benefits, the Company still anticipates EPS for the year endedDecember 31, 2021 to be in the guidance range of$1.10 to$1.20 per share. The information in this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section, nor shall it be deemed subject to the requirements of amended Item 10 of Regulation S-K, nor shall it be deemed incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in such filing. The furnishing of this information hereby shall not be deemed an admission as to the materiality of any such information. Item 9.01 Financial Statements and Exhibits (d)Exhibits. The following exhibits are filed with this Current Report on Form 8-K: Exhibit No. Description 99.1J.P. Morgan Healthcare Conference presentation 104 Cover Page Interactive Data File (embedded within the inline XBRL document)
--------------------------------------------------------------------------------
© Edgar Online, source